Edition:
United Kingdom

Global Blood Therapeutics Inc (GBT.OQ)

GBT.OQ on NASDAQ Stock Exchange Global Select Market

48.87USD
18 Jan 2019
Change (% chg)

$0.96 (+2.00%)
Prev Close
$47.91
Open
$48.15
Day's High
$48.93
Day's Low
$47.77
Volume
237,057
Avg. Vol
368,741
52-wk High
$68.05
52-wk Low
$30.16

Chart for

About

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing therapeutics to treat blood-based disorders. The Company is developing its initial product candidate, GBT440, as an oral, once-daily therapy for sickle cell disease (SCD). The... (more)

Overall

Beta: --
Market Cap(Mil.): $1,412.94
Shares Outstanding(Mil.): 43.68
Dividend: --
Yield (%): --

Financials

  GBT.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -2.47 -- --
ROI: -37.53 8.99 14.48
ROE: -37.85 10.13 15.99

BRIEF-GBT Signs Licensing Agreement For Inclacumab To Treat Vaso-Occlusive Crisis

* GBT EXPANDS SICKLE CELL DISEASE PIPELINE WITH WORLDWIDE LICENSING AGREEMENT FOR INCLACUMAB FOR THE TREATMENT OF VASO-OCCLUSIVE CRISIS

23 Aug 2018

Earnings vs. Estimates